Key Insights

Highlights

Success Rate

78% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

13.8%

4 terminated out of 29 trials

Success Rate

77.8%

-8.7% vs benchmark

Late-Stage Pipeline

28%

8 trials in Phase 3/4

Results Transparency

21%

3 of 14 completed with results

Key Signals

3 with results78% success

Data Visualizations

Phase Distribution

24Total
Not Applicable (11)
Early P 1 (1)
P 2 (4)
P 3 (4)
P 4 (4)

Trial Status

Completed14
Unknown6
Terminated4
Recruiting3
Active Not Recruiting1
Withdrawn1

Trial Success Rate

77.8%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT07095244Not ApplicableRecruiting

Pediatric Outcomes and Recovery With Peri-Operative Iron Supplement Evaluation

NCT07089030Not ApplicableRecruiting

Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy

NCT05544513Phase 2Active Not Recruiting

Oral Iron Supplementation for Patients With Chronic Kidney Disease

NCT06662045RecruitingPrimary

Impact of Iron Deficiency Anemia on Neurobehavioral and Cognitive Development in Children Aged 6 to 24 Months

NCT04949165Not ApplicableCompletedPrimary

Bloodsafe Ghana- Iron and Nutritional Counseling Strategy Pilot Study

NCT05240677Not ApplicableCompleted

Endoscopy in CKD With Iron Deficiency Anemia

NCT04320966Withdrawn

Neurovascular Complications and White Matter Damage in Acquired Anemias

NCT04318405CompletedPrimary

Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE).

NCT05365308Not ApplicableCompletedPrimary

EHR-based Patient Identification and Panel Management of Patients With Iron Deficiency Anemia

NCT01100879Phase 4TerminatedPrimary

Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy

NCT02968368Phase 3Completed

Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease

NCT02341300Not ApplicableTerminatedPrimary

Use of Cast Iron Pots to Improve Maternal Anemia

NCT03232554Phase 2UnknownPrimary

Buxue Yimu Pills for Gynecological Iron-Deficiency Anemia

NCT03411590Not ApplicableUnknown

The Effect of Fortified Growing-up Milk on Growth and Micronutrient Status of Nigerian Toddlers

NCT00298051Not ApplicableCompletedPrimary

Umbilical Cord Clamping and Infant Iron Status

NCT01047098Not ApplicableCompleted

Effects of Taking Prenatal Vitamin-mineral Supplements During Lactation on Iron Status and Markers of Oxidation

NCT02541708Phase 3UnknownPrimary

IV Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Iron Deficiency Anemia at Delivery in Tanzania

NCT03122938Not ApplicableUnknownPrimary

Lactoferrin Supplementation and Iron Metabolism in Healthy Pregnant Women

NCT02498886Early Phase 1CompletedPrimary

IHAT Absorption Kinetics

NCT02998697Phase 2Completed

Short Term Oral Iron Supplementation in Systolic Heart Failure Patients Suffering From Iron Deficiency Anemia

Scroll to load more

Research Network

Activity Timeline